The main patent for Ohtuvayre, the COPD drug at the heart of Verona’s $10 billion sale, expired in 2020. For Merck to make ...

Mouth taping for better sleep is trending on TikTok, but you could waste your money, experts say, if you don’t first learn ...

McDonald discusses her groundbreaking path in interventional pulmonology, overcoming barriers with early lung cancer ...

The Butte County Air Quality Management District and Butte County Public Health have issued a joint air quality advisory due ...

VETS allegedly told a distraught dog owner her beloved Pomeranian was riddled with infection and beyond saving – after they ...

Diabetes may not only lead to joint pain that can severely damage your knee but also increase the risk of infections and ...

The candles on your birthday cake don't tell the whole story. As anyone who ever attended a high-school reunion can tell you, ...

Around the world, several diseases are spreading quickly and, if left unchecked, can create serious issues. In particular, ...

The study led by researchers from the Vardhman Medical College & Safdarjung Hospital, New Delhi, showed that diabetes is a ...

PM2.5 levels in homes across Canada surged past WHO guidelines during June's wildfire smoke, data shows. A company that sells internet-connected home air quality monitors says its data shows PM2.5 ...

MRK's $10B buyout of VRNA brings in Ohtuvayre, a unique COPD therapy set to bolster its cardio-pulmonary portfolio.

Synchrony Medical announced that it received FDA 510 (k) clearance for its LibAirty airway clearance system.